Meghana V Malkan of malkansview.com told CNBC-TV18, "Pharma sector is a good sector. It is comparatively safer when you compare it to other sectors. Aurobindo Pharma definitely looks very good in the short-term. So, one could hold on for a target of Rs 1,600 in the near-term. One could keep a stoploss of Rs 1,360."
At 15:00 hrs Aurobindo Pharma was quoting at Rs 1,449.05, up Rs 30.10, or 2.12 percent on the BSE.
The share touched its 52-week high Rs 1,479.45 and 52-week low Rs 695.55 on 01 July, 2015 and 10 July, 2014, respectively.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
